Blockchain Registration Transaction Record
Anzor Pharmaceuticals CEO to Present Breakthrough Therapy at Chronic Kidney Disease Conference
Anzor Pharmaceuticals CEO presents groundbreaking FGF peptide therapy for chronic kidney disease at conference, offering hope for improved treatments. Learn more about the latest advancements in CKD research and potential impact on patient care.

This news highlights the promising developments in FGF peptide therapy for chronic kidney disease, potentially offering new treatment options for the millions affected by this condition. The presentation's focus on addressing cardiovascular issues associated with CKD showcases the importance of innovative research in improving patient outcomes and quality of life.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x94a1f1fd6b6be5ea06a69cac5a119308e0cdd85d409aa072d8bee6e837162494 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | milkWQRV-6432196c9843681572c9ee282ec7d7a3 |